Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Mohamed
Contact Mohamed, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France
Article Dans Une Revue Cancer Management and Research Année : 2019 Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France Mots clés colorectal cancer KRAS mutation spatial scan statistics carcinogens highways Domaines Cancer Génétique humaine Génétique des populations [q-bio.PE] Hépatologie et Gastroentérologie Origine : Publication financée par une institution Licence : CC BY NC - Paternité - Pas d'utilisation commerciale hal-03323565 , version 1 (27-02-2024)...
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
23 References 419 Citing Articles Letters 1 Comment Related Articles Abstract Background Among patients with metastatic pancreatic cancer, combination chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall survival than gemcitabine therapy. We compared the efficacy and safety of a modified FOLFIRINOX regimen with gemcitabine as adjuvant therapy in patients with resected pancreatic cancer.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mohamed
Contact Mohamed, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack